FORMA THERAPEUTICS HOLDINGS, INC. Operating Cash Flow
FORMA THERAPEUTICS HOLDINGS, INC. reported Operating Cash Flow of -$94.06 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-08-05
- FORMA THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$44.76M.
- FORMA THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$49.30M.
- FORMA THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$41.20M.
- FORMA THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2021-09-30 was -$34.81M.
- FORMA THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$149.79M.
- FORMA THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$95.42M.
- FORMA THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2019 was -$34.49M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$44.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$94.06M 10-Q · filed 2022-08-05 | -$135.26M derived: sum of 3 quarters · filed 2022-08-05 | -$170.07M derived: sum of 4 quarters · filed 2022-08-05 |
| 2022-03-31 | -$49.30M 10-Q · filed 2022-05-06 | -$90.50M derived: sum of 2 quarters · filed 2022-05-06 | -$125.31M derived: sum of 3 quarters · filed 2022-05-06 | -$157.84M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-12-31 | -$41.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$76.01M derived: sum of 2 quarters · filed 2022-03-01 | -$108.55M derived: sum of 3 quarters · filed 2022-08-05 | -$149.79M 10-K · filed 2022-03-01 |
| 2021-09-30 | -$34.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$67.35M derived: sum of 2 quarters · filed 2022-08-05 | -$108.58M 10-Q · filed 2021-11-12 | -$120.90M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-06-30 | -$32.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$73.78M 10-Q · filed 2022-08-05 | -$86.09M derived: sum of 3 quarters · filed 2022-08-05 | -$112.37M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | -$41.24M 10-Q · filed 2022-05-06 | -$53.56M derived: sum of 2 quarters · filed 2022-05-06 | -$79.83M derived: sum of 3 quarters · filed 2022-05-06 | -$103.24M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | -$12.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$38.59M derived: sum of 2 quarters · filed 2022-03-01 | -$62.00M derived: sum of 3 quarters · filed 2022-03-01 | -$95.42M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$26.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$49.68M derived: sum of 2 quarters · filed 2021-11-12 | -$83.10M 10-Q · filed 2021-11-12 | -$93.92M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$23.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$56.83M 10-Q · filed 2021-08-13 | -$67.65M derived: sum of 3 quarters · filed 2021-08-13 | -$94.74M derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | -$33.42M 10-Q · filed 2021-05-14 | -$44.24M derived: sum of 2 quarters · filed 2021-05-14 | -$71.33M derived: sum of 3 quarters · filed 2021-05-14 | |
| 2019-12-31 | -$10.82M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$37.91M derived: sum of 2 quarters · filed 2021-03-30 | -$34.49M 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$27.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$23.67M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $3.42M 10-Q · filed 2020-08-13 |